MedPath

Doxazosin mesylate

DOXAZOSIN MESYLATE TABLETS, USP

Approved
Approval ID

98a248f5-a79b-43ba-839f-014a77edf9c2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2015

Manufacturers
FDA

State of Florida DOH Central Pharmacy

DUNS: 829348114

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

doxazosin mesylate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53808-1017
Application NumberANDA076161
Product Classification
M
Marketing Category
C73584
G
Generic Name
doxazosin mesylate
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 3, 2015
FDA Product Classification

INGREDIENTS (8)

SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
DOXAZOSIN MESYLATEActive
Quantity: 2 mg in 1 1
Code: 86P6PQK0MU
Classification: ACTIM
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Doxazosin mesylate - FDA Drug Approval Details